Profile
Art M.
Pappas founded Pappas Capital Management in 1994, CoLucid Pharmaceuticals, Inc. in 2005, where he worked as Chairman, and Pappas Capital LLC in 1994, where he is working as Managing Partner from 1994.
Mr. Pappas also currently works at MUSC Foundation for Research Development, as Director, Real Endpoints LLC, as Director, OrphoMed, Inc., as Director, and various other companies.
Mr. Pappas also formerly worked at Merrell Dow USA, as Chief Executive Officer-Brazil Region, Glaxo Far East Pte Ltd., as Chief Executive Officer in 1994, Merrell Dow Pharmaceuticals Pacific Ltd., as Chief Executive Officer, and various other companies.
Mr. Pappas received his Masters Business Admin degree from Xavier University and undergraduate degree from The Ohio State University.
Art Pappas active positions
| Companies | Position | Start |
|---|---|---|
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Chief Executive Officer | 31/03/1994 |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Corporate Officer/Principal | 14/05/2013 |
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology Provides biomedical research services | Director/Board Member | - |
OrphoMed, Inc.
OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director/Board Member | - |
A. M. Pappas Life Science Ventures V LP
A. M. Pappas Life Science Ventures V LP Investment ManagersFinance Functions as a venture capital fund | Director/Board Member | - |
Sorriso Pharmaceuticals, Inc.
Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company advancing disease-modifying antibodies for the treatment of inflammatory disease | Director/Board Member | - |
Chiesi Ventures, Inc.
Chiesi Ventures, Inc. Investment ManagersFinance Chiesi Ventures invests in companies located in the United States and Europe. The firm targets companies operating in the fields of rare and orphan disorders. It provides financing from seed and early stage capital requirements with an investment size of USD 4 - 5 million and acts as a lead investor. | Private Equity Investor | - |
Duke Cancer Institute
Duke Cancer Institute Hospital/Nursing ManagementHealth Services Operates cancer center | Consultant / Advisor | - |
MUSC Foundation for Research Development | Director/Board Member | - |
| ░░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Art Pappas
| Companies | Position | End |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Art Pappas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 42 |
|---|---|
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
Embrex LLC
Embrex LLC BiotechnologyHealth Technology Manufactures agricultural and biological products | Health Technology |
Keravision, Inc.
Keravision, Inc. Medical SpecialtiesHealth Technology Develops medical products for the treatment of common vision problems | Health Technology |
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development, marketing & public opinion polling services | Commercial Services |
Valentis, Inc.
Valentis, Inc. Pharmaceuticals: MajorHealth Technology Develops products for urology indications | Health Technology |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Chimerix, Inc.
Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
NuVasive, Inc.
NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
TYRX, Inc.
TYRX, Inc. Electronic Equipment/InstrumentsElectronic Technology Designs and manufactures medical-pharmaceutical combination devices | Electronic Technology |
CardioDx, Inc.
CardioDx, Inc. Medical/Nursing ServicesHealth Services Operates as a cardiovascular genomic diagnostics company | Health Services |
CeNeRx BioPharma, Inc.
CeNeRx BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
LEAD Therapeutics, Inc.
LEAD Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Develops therapeutic drugs | Health Technology |
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders | Health Technology |
Aura Biosciences, Inc.
Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Finance |
Xavier University
Xavier University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selventa, Inc.
Selventa, Inc. Miscellaneous Commercial ServicesCommercial Services Develops new approaches for the understanding and treatment of diseases | Commercial Services |
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology Provides biomedical research services | Health Technology |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services Provides research and education grants | Technology Services |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
MUSC Foundation for Research Development | |
Glaxo Holdings Plc
Glaxo Holdings Plc Financial ConglomeratesFinance Provides investment services | Finance |
Merrell Dow USA | |
Glaxo Far East Pte Ltd. | |
The BioExec Institute, Inc.
The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Commercial Services |
Real Endpoints LLC
Real Endpoints LLC Data Processing ServicesTechnology Services Provides information and analytics services | Technology Services |
Pappas Capital Management
Pappas Capital Management Investment ManagersFinance Provides investment advice | Finance |
Abbott Laboratories International LLC
Abbott Laboratories International LLC Medical DistributorsDistribution Services Wholesales hospital equipment | Distribution Services |
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases | Health Technology |
Chiesi Ventures, Inc.
Chiesi Ventures, Inc. Investment ManagersFinance Chiesi Ventures invests in companies located in the United States and Europe. The firm targets companies operating in the fields of rare and orphan disorders. It provides financing from seed and early stage capital requirements with an investment size of USD 4 - 5 million and acts as a lead investor. | Finance |
OrphoMed, Inc.
OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
AgTech Accelerator Corp.
AgTech Accelerator Corp. Financial ConglomeratesFinance Provides financial services for agriculture companies | Finance |
Merrell Dow Pharmaceuticals Pacific Ltd. | |
Arix Bioscience Plc
Arix Bioscience Plc Investment ManagersFinance Operates as a global venture capital firm | Finance |
A. M. Pappas Life Science Ventures V LP
A. M. Pappas Life Science Ventures V LP Investment ManagersFinance Functions as a venture capital fund | Finance |
Duke Cancer Institute
Duke Cancer Institute Hospital/Nursing ManagementHealth Services Operates cancer center | Health Services |
Allievex Corp.
Allievex Corp. Pharmaceuticals: OtherHealth Technology Develops and manufactures novel therapies for the treatment of rare pediatric neurodegenerative diseases | Health Technology |
Sorriso Pharmaceuticals, Inc.
Sorriso Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company advancing disease-modifying antibodies for the treatment of inflammatory disease | Health Technology |
- Stock Market
- Insiders
- Art Pappas
















